Details for New Drug Application (NDA): 065415
✉ Email this page to a colleague
The generic ingredient in CEFOXITIN is cefoxitin sodium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for 065415
Tradename: | CEFOXITIN |
Applicant: | Acs Dobfar |
Ingredient: | cefoxitin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 065415
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065415 | ANDA | Sagent Pharmaceuticals | 25021-111 | 25021-111-99 | 10 BOTTLE in 1 CARTON (25021-111-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065415 | ANDA | WG Critical Care, LLC | 44567-247 | 44567-247-10 | 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (44567-247-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10GM BASE/VIAL | ||||
Approval Date: | May 19, 2010 | TE: | AP | RLD: | No |
Complete Access Available with Subscription